Community Pharmacy-Based Injectable Opioid Agonist Treatment: Findings From a Canadian Pilot Program
Mihic T, Socias ME, McCrae K, Johnson C, Nolan S, Grant C, Sutherland C, Fairbairn N., Drug Alcohol Rev. 2026
The association between benzodiazepine proliferation in the unregulated drug supply and experiences of violence: A gender-based analysis
Swaich A, Rufus-Sedgemore K, Choi J, DeBeck K, Boyd J, Milloy MJ, Kerr T, Hayashi K., Drug Alcohol Depend. 2026
Les enjeux de l’usage de stimulants, de la psychose et du traitement antipsychotique chez les jeunes consommateurs de drogues : une étude qualitative longitudinale
Goodyear T, Thulien M, Anghel A, Slemon A, Jensen M, Ignaszewski MJ, Sassi R, Mathias S, Jenkins E, Knight R, Fast D. , Soc Sci Med. 2025
Re-making selves and social worlds: Experiences of live-in substance use treatment among adolescents experiencing social structural marginalization in Vancouver
Sandhu M, Thulien M, Eekhoudt CR, Friesen D, Moore E, Ignaszewski M, Bagley S, Motta-Ochoa R, Jenkins E, Fast D, SSM Qual Res Health, 2025.
“Trying to get down here when the dealer’s closer”: Place and participation in clinical trials for substance use disorders
Jaffe K, Jutras-Aswad D, Richardson L., Soc Sci Med. 2025
Prédiction de la mortalité due à une intoxication médicamenteuse chez les personnes vivant avec une co-infection VIH-VHC
Mélanie Bédard, Erica Em Moodie, Joseph Cox, John Gill, Sharon Walmsley, Valérie Martel‑Laferrière, Curtis Cooper, Marina B Klein, Canadian Liver Journal, 2025
A pilot randomized controlled trial of a digital cannabis harm reduction intervention for young adults with first-episode psychosis who use cannabis
Coronado-Montoya S, Abdel-Baki A, Bodson-Clermont P, Boucher-Roy D, Côté J, Crocker CE, Crockford D, Daneault JG, Dubreucq S, Dussault-Laurendeau M, Fischer B, Lachance-Touchette P, Lecomte T, L’Heureux S, Ouellet-Plamondon C, Roy MA, Tatar O, Tibbo PG, Villeneuve M, Wittevrongel A, Jutras-Aswad D., Psychiatry Res. 2025
Les schémas de consommation de substances polysomatiques et les surdosages non mortels : une analyse latente de classes à mesures répétées
Karamouzian M, Cui Z, Hayashi K, DeBeck K, Reddon H, Buxton J, Kerr T, Int J Drug Policy
Policing and access to harm reduction services among young people who use drugs and young Indigenous people who use drugs before and after the pilot implementation of decriminalization of personal possession
McAdam E, Milloy MJ, Sayre EC, Verdicchio C, Sedgemore K, May H, Pranteau S, Corriveau D, Friesen D, Fleury M, Fast D, DeBeck K, Int J Drug Policy READ MORE
A scoping review and concept analysis to inform Canada’s safe(r) opioid supply research agenda
Uyen Do, Sarah Larney, Matthew Bonn, Ingrid Matei, Camille Zolopa, Amy Bergeron, Mohammad Karamouzian, Elaine Hyshka, Thomas D. Brothers, Nikki Bozinoff, Dan Werb, Didier Jutras‑Aswad, Stine Høj, Isabelle Boisvert, Igor Yakovenko, Julie Bruneau, International Journal of Drug Policy, 2025